Keyphrases
National Cohort Study
100%
Confidence Interval
80%
Atrial Fibrillation
76%
Heart Failure
65%
Myocardial Infarction
62%
Out-of-hospital Cardiac Arrest
59%
Hazard Ratio
54%
Denmark
53%
All-cause Mortality
37%
Cardiovascular Mortality
29%
Nationwide Registry
28%
Incidence Rate
25%
Cardiovascular Risk
22%
Comorbidity
22%
Patients with Heart Failure
21%
Odds Ratio
21%
Acute Myocardial Infarction
21%
Diabetes
19%
Cardiovascular Disease
17%
Nationwide Registers
17%
Heart Failure Patients
16%
Mortality Risk
15%
Register Study
15%
Beta-blockers
15%
COVID-19
14%
Infective Endocarditis
14%
Risk Factors
14%
Risk of Death
14%
Cardiovascular Outcomes
14%
Type 2 Diabetes Mellitus (T2DM)
13%
Hypertension
13%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
13%
Hospitalization
12%
Cardiovascular Events
12%
High Risk
12%
Clopidogrel
11%
Bleeding
11%
AIMS™
11%
Temporal Trends
11%
Vitamin K Antagonists
11%
Ischemic Stroke
11%
Stroke Risk
11%
Absolute Risk
11%
Thromboembolism
11%
Ischemic Heart Disease
10%
Type 2 Diabetic Patients
10%
Automated External Defibrillator
10%
Bleeding Risk
10%
Cardiac Arrest
10%
Registry-based
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
92%
Heart Failure
71%
Atrial Fibrillation
66%
Heart Infarction
61%
All Cause Mortality
31%
Out of Hospital Cardiac Arrest
25%
Cardiovascular Disease
25%
Disease
18%
Anticoagulant Agent
18%
Comorbidity
18%
Acute Heart Infarction
18%
Non Insulin Dependent Diabetes Mellitus
16%
Cardiovascular Risk
16%
Bleeding
14%
Thromboembolism
14%
Antivitamin K
14%
Acetylsalicylic Acid
12%
Beta Adrenergic Receptor Blocking Agent
12%
Diabetes Mellitus
12%
Pharmacotherapy
11%
Brain Ischemia
10%
Clopidogrel
10%
Prevalence
10%
Infection
10%
Cardiovascular Mortality
10%
Rivaroxaban
9%
Non-Steroidal Anti-Inflammatory Drug
9%
Ischemic Heart Disease
9%
Coronavirinae
8%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Chronic Obstructive Lung Disease
8%
Bacterial Endocarditis
8%
Malignant Neoplasm
8%
Congestive Heart Failure
8%
Acute Coronary Syndrome
7%
Warfarin
7%
Population Study
7%
Dabigatran
7%
Obesity
7%
Heart Arrest
6%
Antiplatelet
6%
Apixaban
6%
Placebo
6%
Chronic Kidney Failure
6%
Adverse Event
6%
Isotopes of Potassium
6%
Venous Thromboembolism
5%
Coronary Artery Disease
5%
Dronedarone
5%
Faintness
5%
Medicine and Dentistry
Cohort Analysis
76%
Heart Failure
58%
Atrial Fibrillation
51%
Out of Hospital Cardiac Arrest
41%
Cardiovascular System
39%
Hazard Ratio
35%
Myocardial Infarction
33%
Apoplexy
29%
Cardiovascular Disease
21%
Diabetes
19%
All Cause Mortality
15%
COVID-19
15%
Resuscitation
13%
Odds Ratio
12%
Antithrombotic
12%
Infective Endocarditis
12%
Cardiovascular Risk
12%
Proportional Hazards Model
11%
Drug Therapy
11%
Disease
10%
Maturity Onset Diabetes of the Young
10%
Implantable Automatic Defibrillator
10%
Acute Coronary Syndrome
10%
Thromboembolism
9%
Heart Arrest
9%
Ischemic Heart Disease
9%
Diabetes Mellitus
8%
Coronary Angiography
8%
Triage
8%
Infection
8%
Brain Ischemia
8%
Nonsteroid Antiinflammatory Agent
8%
Logistic Regression Analysis
7%
Nursing Home
7%
Defibrillation
7%
Prevalence
7%
Defibrillator
7%
Patient with Type 2 Diabetes
6%
Cardiovascular Mortality
6%
Population
6%
Chronic Kidney Disease
6%
Malignant Neoplasm
6%
Anticoagulation
6%
Congestive Heart Failure
6%
Ambulatory Blood Pressure
6%
Acute Heart Infarction
6%
Blood Pressure
6%
Mortality Rate
5%
Risk Stratification
5%
Vitamin K Antagonist
5%
